Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 11, 1997

View Archived Issues

Company Profile: Epicyte

Company Profile: Point Therapeutics

Proof of principle demonstrated for Titan's drug delivery system

Aronex's Nyotran shown effective against aspergillosis

ICAgen receive SBIR grant for ion channel drug target research

Cell Genesys: Q3 1997 highlights

Roberts: Q3 1997 highlights

New oxazolidinone antibiotics described by Zeneca

Neurogen describes dopamine receptor subtype-specific ligands

PPAR-gamma agonists for endocrine and metabolic disorders

Azolobenzazepines claimed by Zeneca for use in stroke

Fujisawa reports heterocyclic glutamate receptor antagonists

MK-966 assessed in large trial in osteoarthritis of the knee and hip

New C5a antagonist reduces cardiac ischemia-reperfusion injury in micropig model

Atypical antipsychotic developed at Esteve characterized

ImaRx presents new ultrasound contrast agent for detecting thrombosis

PNU-96293: KATP channel blocker and eukalemic diuretic

Selective PDE V inhibition with M-54033 beneficial in pulmonary hypertension

Recordati signs licensing agreements with Zeneca, Zambon and Rotta for lercanidipine

Raxar approved in 12 EU countries

DepoCyt to be reviewed by FDA advisory committee this month

Clinical results reported for Roche Bioscience's nepicastat

Humanized anti-CD4 MAb suppresses synovial inflammation/cytokine levels

Orphan Medical receives approvable letter from FDA for Sucraid

FDA clears new indication for Zocor

Clinical results reported for leflunomide in refractory RA and Wegener's granulomatosis

Calcium sensitizer a valuable treatment option for decompensated HF

Roberts completes phase Ia trial of LY-315535

rhIL-1ra provides long-term improvement in RA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...